Triazolam
Active substance: triazolam
TABLET · TRIAZOLAM .125 mg/1
United StatesActive
Marketing holder: Mylan Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRIAZOLAM · .125 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-2d1a-7649-9767-0b3822b39432,01a1208c-5c5b-753f-ac81-51b25d47f8ca,01a1208c-6cbc-78b0-92ec-64872b83bbec,01a1208c-8204-7bec-9679-d93c42f822ec,01a1208d-325f-7dae-8962-63d7c178290e;count=14 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59762-3717
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 59762-3717 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59762-3717 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59762-3717 · Verified 2026-10-09 · open in source